News & Updates

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

Patients with asymptomatic uricaemia or gout may do well to keep their serum uric acid levels below 6.0 mg/dL, which has been shown to minimize the occurrences of gout flare in a recent study.

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

01 Jul 2021

RATIONALE 302: Tislelizumab beats chemo in advanced ESCC

01 Jul 2021 by

Treatment with tislelizumab led to a significantly improved overall survival (OS) in patients with advanced or metastatic oesophageal squamous cell carcinoma (ESCC) compared with chemotherapy in the second-line setting, according to the RATIONALE 302* study presented at ASCO 2021.

RATIONALE 302: Tislelizumab beats chemo in advanced ESCC

01 Jul 2021

Acalabrutinib maintains efficacy over 4 years in treatment-naïve CLL

30 Jun 2021 by

Acalabrutinib with or without obinutuzumab maintains significant progression-free survival (PFS) benefit over the chemoimmunotherapy combination of obinutuzumab plus chlorambucil (O + Clb) through 4 years in treatment-naïve chronic lymphocytic leukaemia (CLL) patients, according to the phase III ELEVATE-TN study presented at EHA 2021.

Acalabrutinib maintains efficacy over 4 years in treatment-naïve CLL

30 Jun 2021

Statins do not induce cognitive decline, dementia in older adults

30 Jun 2021

Statin therapy does not appear to lead to incident dementia, mild cognitive impairment (MCI), or declines in individual cognitive domains among adults aged ≥65 years, according to a study.

Statins do not induce cognitive decline, dementia in older adults

30 Jun 2021

$Cabozantinib a new SoC for previously treated RAI-refractory DTC?$

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021 by

In individuals with radio-iodine-refractory differentiated thyroid cancer (RAI-refractory DTC) who have progressed during/after prior VEGFR-targeted therapy, the VEGFR2/MET/AXL/RET inhibitor cabozantinib showed a significant progression-free survival (PFS) benefit, according to findings of the phase III COSMIC-311 trial presented at ASCO 2021.

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

30 Jun 2021

Delay in antimicrobial treatment can hurt patients with suspected infection

30 Jun 2021

Putting off the administration of antimicrobial therapy in patients with suspected infection is risky and may lead to progression to septic shock, a study has found.

Delay in antimicrobial treatment can hurt patients with suspected infection

30 Jun 2021

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

30 Jun 2021

In the treatment of patients with young-onset diabetes, adding dipeptidyl peptidase-4 (DPP-4) inhibitors contributes to lower risks of hospitalization and death compared with sulfonylureas, according to a study.

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

30 Jun 2021

Extension studies highlight ozanimod safety in moderate-to-severe UC

29 Jun 2021 by

An analysis of patients with moderately to severely active ulcerative colitis (UC) highlighted the general safety of the oral sphingosine-1-phosphate (S1P) receptor 1 and 5 modulator ozanimod, according to a presentation at Digestive Disease Week 2021.

Extension studies highlight ozanimod safety in moderate-to-severe UC

29 Jun 2021

UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP

29 Jun 2021 by

Among women with intrahepatic cholestasis of pregnancy (ICP), ursodeoxycholic acid (UDCA) treatment was associated with a reduction in the risk of composite adverse perinatal outcomes of stillbirth and preterm birth (PTB), a meta-analysis suggests.

UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP

29 Jun 2021

Botox injections help correct ocular alignment in individuals with strabismus

29 Jun 2021

Administering extraocular muscle injection of botulinum toxin type A (BTXA) to individuals with nonparalytic, nonrestrictive horizontal strabismus yields a high rate of successful motor alignment similar to that achieved with eye muscle surgery, according to the results of a systematic review and meta-analysis.

Botox injections help correct ocular alignment in individuals with strabismus

29 Jun 2021

News & Updates

Filter by Specialty:

Specialty:

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

Serum uric acid control helps prevent gout flare in asymptomatic hyperuricaemia, gout

RATIONALE 302: Tislelizumab beats chemo in advanced ESCC

RATIONALE 302: Tislelizumab beats chemo in advanced ESCC

Acalabrutinib maintains efficacy over 4 years in treatment-naïve CLL

Acalabrutinib maintains efficacy over 4 years in treatment-naïve CLL

Statins do not induce cognitive decline, dementia in older adults

Statins do not induce cognitive decline, dementia in older adults

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

Cabozantinib a new SoC for previously treated RAI-refractory DTC?

Delay in antimicrobial treatment can hurt patients with suspected infection

Delay in antimicrobial treatment can hurt patients with suspected infection

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

DPP-4 inhibitors a suitable second-line treatment for young-onset diabetes

Extension studies highlight ozanimod safety in moderate-to-severe UC

Extension studies highlight ozanimod safety in moderate-to-severe UC

UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP

UDCA tied to reduction in risk of stillbirth, preterm birth in women with ICP

Botox injections help correct ocular alignment in individuals with strabismus

Botox injections help correct ocular alignment in individuals with strabismus